Literature DB >> 19317667

Method for improving sequence coverage uniformity of targeted genomic intervals amplified by LR-PCR using Illumina GA sequencing-by-synthesis technology.

Olivier Harismendy1, Kelly Frazer.   

Abstract

One approach for high-throughput population-based sequencing of targeted intervals in the human genome is to amplify the regions using long-range PCR (LR-PCR) followed by sequencing with next-generation sequencing (NGS) technologies. Utilizing this method, we have observed that the 50 bp located at the amplicon ends account for more than 50% of the sequenced bases and that the sequence coverage depth of base pairs within an amplicon is highly variable. Here we propose an explanation for the overrepresentation of the amplicon ends and show that the use of 5'-blocked primers for the LR-PCR reaction reduces their overrepresentation. Furthermore, we demonstrate that using a 600-bp library insert size rather than the standard 200-bp insert size results in more uniform sequence coverage depth. The capability to increase sequence coverage uniformity greatly improves the effective throughput of NGS platforms.

Entities:  

Mesh:

Year:  2009        PMID: 19317667     DOI: 10.2144/000113082

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  31 in total

1.  Next-generation sequencing for cancer diagnostics: a practical perspective.

Authors:  Cliff Meldrum; Maria A Doyle; Richard W Tothill
Journal:  Clin Biochem Rev       Date:  2011-11

2.  Multi-sample pooling and illumina genome analyzer sequencing methods to determine gene sequence variation for database development.

Authors:  Rebecca L Margraf; Jacob D Durtschi; Shale Dames; David C Pattison; Jack E Stephens; Rong Mao; Karl V Voelkerding
Journal:  J Biomol Tech       Date:  2010-09

Review 3.  Target-enrichment strategies for next-generation sequencing.

Authors:  Lira Mamanova; Alison J Coffey; Carol E Scott; Iwanka Kozarewa; Emily H Turner; Akash Kumar; Eleanor Howard; Jay Shendure; Daniel J Turner
Journal:  Nat Methods       Date:  2010-02       Impact factor: 28.547

4.  Comparison of the Illumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes.

Authors:  Shale Dames; Jacob Durtschi; Katherine Geiersbach; Jack Stephens; Karl V Voelkerding
Journal:  J Biomol Tech       Date:  2010-07

Review 5.  The next-generation sequencing technology and application.

Authors:  Xiaoguang Zhou; Lufeng Ren; Qingshu Meng; Yuntao Li; Yude Yu; Jun Yu
Journal:  Protein Cell       Date:  2010-07-07       Impact factor: 14.870

6.  Variant identification in multi-sample pools by illumina genome analyzer sequencing.

Authors:  Rebecca L Margraf; Jacob D Durtschi; Shale Dames; David C Pattison; Jack E Stephens; Karl V Voelkerding
Journal:  J Biomol Tech       Date:  2011-07

7.  Rapid deep sequencing of patient-derived HIV with ion semiconductor technology.

Authors:  Max W Chang; Glenn Oliveira; Jinyun Yuan; Jason F Okulicz; Samuel Levy; Bruce E Torbett
Journal:  J Virol Methods       Date:  2013-02-04       Impact factor: 2.014

8.  Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing.

Authors:  Lance D Eckerle; Michelle M Becker; Rebecca A Halpin; Kelvin Li; Eli Venter; Xiaotao Lu; Sana Scherbakova; Rachel L Graham; Ralph S Baric; Timothy B Stockwell; David J Spiro; Mark R Denison
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

9.  Ultra high throughput sequencing in human DNA variation detection: a comparative study on the NDUFA3-PRPF31 region.

Authors:  Paola Benaglio; Carlo Rivolta
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

10.  Ultra high throughput sequencing excludes MDH1 as candidate gene for RP28-linked retinitis pigmentosa.

Authors:  Thomas Rio Frio; Sylwia Panek; Christian Iseli; Silvio Alessandro Di Gioia; Arun Kumar; Andreas Gal; Carlo Rivolta
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.